Jiangsu Hengrui Pharmaceuticals Co., Ltd. (1276N)
BMV
104.64
0.00 (0.00%)
Closed
Oct 6, 2026
Day's Range
104.64104.64
52 wk Range
104.64125.92
Financial Statements - 1276N - Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Revenue
31.62B
Net Income
7.71BNet Margin 24.4%
EBITDA
9.49B
Free Cash Flow
8.27B
Income Statement
| Period Ending | 2025-12-31 |
|---|---|
| Sales | 31.62B |
| Cost of Goods | 4.36B |
| Gross Profit | 27.26B |
 Operating Expense | - |
| Operating Income | 8.59B |
| Non-Operating Interest | - |
| Other Income Expense | - |
| Pre Tax Income | 8.70B |
| Income Tax | 990.62M |
| Net Income | 7.71B |
| EPS Basic | 1.19 |
| EPS Diluted | 1.18 |
| Basic Shares Outstanding | 6.47B |
| Diluted Shares Outstanding | 6.47B |
| Ebit | 8.72B |
| Ebitda | 9.49B |
| Net Income Continuous Operations | 7.71B |
| Minority Interests | -5.94M |
| Preferred Stock Dividends | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
